The nation of Zimbabwe has rejected a major American health deal worth $367m (272 million pounds) over five years over Washington's request for sensitive data.
The decision became public following a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa believed the deal was "unbalanced".
A government representative has since explained that the United States was seeking health data for research and profit but refused to guarantee the resulting advantages from any future medical innovations.
"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.
A medical body in Zimbabwe has appealed for more negotiations to reach a agreement suitable to both sides so the country's vital HIV treatment initiative can be sustained.
Wider Context
This development comes after a similar situation in Kenya, where a court suspended a related deal with the US after legal challenges were filed about the security of Kenyans' medical information.
After returning to the presidency recently, US President Donald Trump has slashed foreign aid and shut down the key foreign aid agency.
USAID had overseen assistance for the American government, but Trump stated its expenditure was "inefficient" and his administration was seeking government-to-government agreements to boost transparency and responsibility.
Based on statements, Sixteen nations in Africa have to date signed similar agreements, constituting over $18.3bn in committed funds.
Details of the Declined Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this cooperation could have provided significant benefits for Zimbabwean communities, especially the 1.2 million presently receiving HIV treatment via US-supported initiatives," the Ambassador said.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"Zimbabwe was being asked to surrender its genetic material and health information for a long time, with no corresponding promise of access to any medical innovations – like vaccines, diagnostics, or treatments – that might result from that shared data," Mangwana explained.
"In essence, our country would supply the raw materials for medical research with no certainty that the resulting innovations would be available to our people should a new health crisis arise."
Sovereignty and International Frameworks
He also noted that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting structures previously established via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme created to manage potential pandemics.
"This mechanism is designed to ensure that when a country provides its information, the resulting advantages – including vaccines and treatments – are shared equitably, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations over the US deal "must not be interpreted as opposition to America," Mangwana stressed.
"We are open to continued dialogue with our American counterparts on how subsequent co-operation could be arranged in a manner that respects the independence and dignity of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it acknowledged the government's concerns, but recommended that talks need to persist since a large portion of the country's Aids initiatives relied on external financing.
"Where technical issues exist, such as those involving information security or agreement terms, these can often be addressed through technical clarification and negotiated safeguards," the group added.
This impasse emphasises the continuing challenges between receiving crucial international aid and protecting national sovereignty in an increasingly data-driven world.